ClassID:

94168

C07D211/54 - CPC Classification

Classification description:

Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Sulfur atoms

Recent Application in this class:
#1
20250257035
2025-08-14

1,4-Substituted Piperidine Derivatives

#2
20250115591
2025-04-10

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

#3
20240425454
2024-12-26

IONIZABLE CATIONIC COMPOUND

#4
20240400516
2024-12-05

PROCESSES FOR THE PREPARATION OF 1,2,3,5,6,7-HEXAHYDRO-S-INDACENE DERIVATAIVES

#5
20240366518
2024-11-07

COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF

#6
20240361688
2024-10-31

ONIUM SALT, RESIST COMPOSITION, AND PATTERN FORMING PROCESS

#7
20240279168
2024-08-22

LIGAND COMPOUND AND INORGANIC NANOPARTICLE-COMPLEX INCLUDING THE SAME

#8
20240208904
2024-06-27

CRYSTALLINE POTASSIUM SALT OF 1-ETHYL- N -((1,2,3,5,6,7-HEXAHYDRO- S -INDACEN-4-YL)CARBAMOYL)PIPERIDINE-4 -SULFONAMIDE

#9
20240173267
2024-05-30

COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF

#10
20240150291
2024-05-09

PROCESS FOR THE PREPARATION OF NLRP3 INHIBITORS

#11
20230391723
2023-12-07

1,4-substituted piperidine derivatives

#12
20230286913
2023-09-14

INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF

#13
20230242484
2023-08-03

NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC APPARATUS USING SAME

#14
20230242465
2023-08-03

COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE

#15
20230174470
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

#16
20230174465
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

#17
20230172066
2023-06-01

LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME

#18
20230150927
2023-05-18

Cannabigerol derivatives and use thereof as cannabinoid receptor modulators

#19
20230147959
2023-05-11

COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE

#20
20230139393
2023-05-04

Nitrogen-containing compound, electronic component using same and electronic device

#21
20230134776
2023-05-04

Cannabinoid derivatives

#22
20230037255
2023-02-02

Sulfonamide carboxamide compounds

#23
20230022917
2023-01-26

N-acyl-{4-[(4-aryl-phenyl)sulfonylmethyl]piperidine} compounds and their therapeutic use

#24
20230002417
2023-01-05

ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES

#25
20220348597
2022-11-03

ORGANIC LIGHT EMITTING DEVICE

#26
20220348522
2022-11-03

ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE

#27
20220267260
2022-08-25

COMPOUNDS CONTAINING A SULFONIC GROUP AS KAT INHIBITORS

#28
20220089555
2022-03-24

N-benzyl-N-arylsulfonamide derivative and preparation and use thereof

#29
20220024920
2022-01-27

ADO-resistant cysteamine analogs and uses thereof

#30
20210230176
2021-07-29

Hepatitis B antiviral agents

#31
20210230116
2021-07-29

1,4-substituted piperidine derivatives

#32
20210093618
2021-04-01

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#33
20210032214
2021-02-04

Compounds for binding proprotein convertase subtilisin/kexin type 9

#34
20210009519
2021-01-14

HISTONE DEACETYLASE INHIBITORS

#35
20200339635
2020-10-29

CRYSTAL STRUCTURE OF THE LARGE RIBOSOMAL SUBUNIT FROM S. AUREUS

#36
20200339549
2020-10-29

CXCR2 antagonist

#37
20200291003
2020-09-17

Sulfonamide carboxamide compounds

#38
20200283697
2020-09-10

Hydrolytically labile heterocycles of odoriferous ketones or odoriferous aldehydes

#39
20200199143
2020-06-25

Hepatitis B antiviral agents

#40
20200148696
2020-05-14

Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof

#41
20200131232
2020-04-30

Crystal structure of the large ribosomal subunit from

#42
20200108054
2020-04-09

SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF

#43
20190382342
2019-12-19

Histone deacetylase inhibitors

#44
20190152913
2019-05-23

1,4-substituted piperidine derivatives

#45
20190119236
2019-04-25

COMPOUNDS FOR BINDING PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)

#46
20190112269
2019-04-18

Hydrobromide salt of N-(4-chloro-2-hydroxy-3-((3S)-3-piperidinylsulfonyl)phenyl-N′-(3-Fluoro-2-methylphenyl)urea

#47
20190100510
2019-04-04

Bromotriazole intermediates

#48
20190084994
2019-03-21

Hepatitis B antiviral agents

#49
20190010135
2019-01-10

1-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitors

#50
20180354901
2018-12-13

Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their use

#51
20180319773
2018-11-08

Triazole agonists of the APJ receptor

#52
20180312482
2018-11-01

Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same

#53
20180179159
2018-06-28

1,4-substituted piperidine derivatives

#54
20180162827
2018-06-14

RADIOMITIGATING PHARMACEUTICAL FORMULATIONS

#55
20180079722
2018-03-22

HYDROBROMIDE SALT OF N-(4-CHLORO-2-HYDROXY-3-((3S)-3-PIPERIDINYLSULFONYL)PHENYL-N'-(3-FLUORO-2-METHYLPHENYL)UREA

#56
20180009853
2018-01-11

Crystal structure of the large ribosomal subunit from

#57
20170334841
2017-11-23

TETRACYCLINE COMPOUNDS

#58
20170253609
2017-09-07

Hepatitis B antiviral agents

#59
20170247387
2017-08-31

Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof

#60
20170073331
2017-03-16

Guanidine compounds and use thereof

#61
20170044131
2017-02-16

Methods for preparing triazole agonists of the APJ receptor

#62
20170042897
2017-02-16

Intermediates for preparing triazole agonists of the APJ receptor

#63
20170042872
2017-02-16

Triazole agonists of the APJ receptor

#64
20170042871
2017-02-16

Triazole agonists of the APJ receptor

#65
20170037026
2017-02-09

Triazole agonists of the APJ receptor

#66
20170035744
2017-02-09

Intermediates for preparing triazole agonists of the APJ receptor

#67
20170002004
2017-01-05

ADO-resistant cysteamine analogs and uses thereof

#68
20160368874
2016-12-22

1,4-substituted piperidine derivatives

#69
20160340336
2016-11-24

Triazole agonists of the APJ receptor

#70
20160332963
2016-11-17

12-epi pleuromutilins

#71
20160326115
2016-11-10

Heterocyclic sulfone RORγ modulators

#72
20160264525
2016-09-15

Hydrobromide salt of N-(4-chloro-2-hydroxy-3-((3S)-3-piperidinylsulfonyl)phenyl-N'-(3-fluoro-2-methylphenyl)urea

#73
20160221976
2016-08-04

Radiomitigating pharmaceutical formulations

#74
20160130227
2016-05-12

PRODRUGS OF ANTI-PLATELET AGENTS

#75
20160090369
2016-03-31

Radiomitigating pharmaceutical formulations

#76
20150252038
2015-09-10

Substituted benzamides and methods of use thereof

#77
20140005176
2014-01-02

2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders

#78
20130324556
2013-12-05

Protease Activated Receptor 2 (PAR2) Antagonists

#79
20130165422
2013-06-27

Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application

#80
20130116216
2013-05-09

Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof

#81
20130053571
2013-02-28

Pleuromutilins and process for the preparation of pleuromutilins

#82
20120316173
2012-12-13

Compounds which modulate the CB2 receptor

#83
20120208788
2012-08-16

Tetracycline compounds

#84
20120108573
2012-05-03

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

#85
20120046276
2012-02-23

Tuberculosis treatment using pleuromutilin derivatives

#86
20120022076
2012-01-26

Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK

#87
20110295014
2011-12-01

PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES

#88
20110257389
2011-10-20

Cross-linked cyclic amine compounds and agents for pest control

#89
20110105563
2011-05-05

IL-8 RECEPTOR ANTAGONISTS

#90
20110098276
2011-04-28

Oxycarbamoyl compounds and the use thereof

#91
20110086880
2011-04-14

NOVEL ALKYL SUBSTITUTED PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS

#92
20110077269
2011-03-31

Derivatives for modulation of ion channels

#93
20110059937
2011-03-10

IL-8 RECEPTOR ANTAGONISTS

#94
20100249147
2010-09-30

Sulfonyl-substituted 6-membered ring derivative

#95
20100168080
2010-07-01

NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS

#96
20100160266
2010-06-24

ORGANIC COMPOUNDS

#97
20100010227
2010-01-14

Process for production of piperidine derivatives

#98
20090318694
2009-12-24

Cross-linked cyclic amine compounds and agents for pest control

#99
20090286771
2009-11-19

2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders

#100
20090259046
2009-10-15

Cyclic amine compounds and agents for pest control

#101
20090253748
2009-10-08

Process for the preparation of pleuromutilins

#102
20090247522
2009-10-01

Hsp90 family protein inhibitors

#103
20090215820
2009-08-27

Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

#104
20090209584
2009-08-20

Antibacterial mutilins

#105
20090131419
2009-05-21

Sulphones which modulate the action of gamma secretase

#106
20090093451
2009-04-09

IL-8 Receptor Antagonists

#107
20090082457
2009-03-26

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#108
20090042883
2009-02-12

ANTITUMOR AGENT

#109
20080275086
2008-11-06

Dpp-Iv Inhibitors

#110
20080161354
2008-07-03

Stable S-nitrosothiols, method of synthesis and use

#111
20080096936
2008-04-24

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

#112
20080058340
2008-03-06

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#113
20070293495
2007-12-20

BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS

#114
20070270404
2007-11-22

Tuberculosis treatment using pleuromutilin derivatives

#115
20070249672
2007-10-25

IL-8 receptor antagonists

#116
20070213329
2007-09-13

Sulphones which modulate the action of gamma-secretase

#117
20070203122
2007-08-30

Derivatives for modulation of ion channels

#118
20070167487
2007-07-19

Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

#119
20070167426
2007-07-19

Compounds for the treatment of inflammatory disorders and microbial diseases

#120
20070155725
2007-07-05

2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders

#121
20070135483
2007-06-14

Antibacterial mutilins

#122
20070112029
2007-05-17

Piperidine compound and process for preparing the same

#123
20070032532
2007-02-08

Hsp90 family protein inhibitors

#124
20060264464
2006-11-23

Amidino compounds as cysteine protease inhibitors

#125
20060223829
2006-10-05

Hydroxysteroid dehydrogenase inhibitors

#126
20060211735
2006-09-21

4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor

#127
20060211734
2006-09-21

(Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-HTagonists

#128
20060205769
2006-09-14

Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity

#129
20060178366
2006-08-10

Compounds for the treatment of inflammatory disorders

#130
20060173044
2006-08-03

Substituted propargylamines

#131
20060167044
2006-07-27

Piperidine derivatives and their use as anti-inflammatory agents

#132
20060084688
2006-04-20

Aromatic sulfone hydroxamic acid metalloprotease inhibitor

#133
20050272771
2005-12-08

Process for production of piperidine derivatives

#134
20050250811
2005-11-10

Pleuromutilin derivatives as antimicrobials

#135
20050239829
2005-10-27

Piperidine compounds

#136
20050234109
2005-10-20

β-amyloid protein production/secretion inhibitor

#137
20050215637
2005-09-29

Tuberculosis treatment

#138
20050075374
2005-04-07

Sulfonyl aryl or heteroaryl hydroxamic acid compounds

#139
20050070520
2005-03-31

Aza-cyclic compounds as modulators of acetylcholine receptors

#140
20050043533
2005-02-24

Process for making alpha-substituted hydroxamic acids

#141
19214766
2025-12-23

Method for preparing cyano sulfonyl fluoride compounds